ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- Medical Image PerceptionIX Conference, Airlie House, Warrenton, VA
September 20-23, 2001
Topics, among others: Detection errors and optimal human and machine "Visual search"; Observer models; Computer-aided fusion of image features and computer-aided detection and diagnosis; Soft-copy displays: technological and human factors; and Assessment methodologies, e.g., ROC analysis with reader random effects.
- Academy of Molecular Imaging Meeting
October 24-28, 2001.
- REQUIRED EDUCATION IN THE PROTECTION OF HUMAN RESEARCH PARTICIPANTS (NOT-OD-01-061)
In an effort to streamline the submission of the required documentation, NIH staff will now accept a letter signed by the official authorized to represent the institution. It is not required that the principal investigator also sign the letter. The letter should continue to be submitted in accordance with Just-in-Time procedures.
- ARCHIVE-COMM-L Medical Image Archive Listserver
The Cancer Imaging Program from the NCI has appointed a steering committee to advise the NIH on matters related to medical image archives. In particular, this advisory group has met to identify the principal issues in the field, and outline an approach to discuss and resolve them. As part of this process, a listserver was established under the auspices of the NIH (http://list.nih.gov) which is titled ARCHIVE-COMM-L. The advisory committee in collaboration with CIP staff has elected to "open" the list and its archives to the public. Anyone may join the list. To join the list, please go to the home page (http://list.nih.gov/archives/archive-comm-l.html) and select the option "Join or leave the list,...". This will select a new page that allows you to join or leave the ARCHIVE-COMM-L list.
- POLICY OF THE NATIONAL CANCER INSTITUTE FOR ALLOWABLE BUDGET LEVELS OF COMPETING CONTINUATION (TYPE 2) R01 AND U01 APPLICATIONS - MODIFICATION AND CLARIFICATION (NOT-CA-01-019)
The National Cancer Institute (NCI) recently published in the NIH Guide NOTICE: NOT-CA-01-016, "POLICY OF THE NATIONAL CANCER INSTITUTE FOR ALLOWABLE REQUESTED BUDGET LEVELS OF COMPETING CONTINUATION (TYPE 2) R01 and U01 APPLICATIONS", Release Date: August 7, 2001 at: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-01-016.html
The policy previously published will be retained, but in response to questions from awardees, a modification and two clarifications are listed below.
- ADDITIONAL INFORMATION AND FAQs ABOUT THE REVISED PHS 398 AND PHS 2590 INSTRUCTIONS AND FORMS (NOT-OD-01-054)
This notice is an addendum to NOT-OD-01-049, entitled "REVISED PHS 398 AND PHS 2590 NOW AVAILABLE", which was previously published on July 10, 2001 in the NIH Guide for Grants and Contracts (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-049.html). NIH has received comments and suggestions from the research community on how NIH can enhance the PHS 398 and PHS 2590 to make them more user-friendly. … Applicants are urged to always check the PHS 398 and PHS 2590 websites to download the most current versions of the instructions and forms prior to submission of an application to NIH.
- IMAGING PANCREATIC BETA CELL MASS, FUNCTION, ENGRAFTMENT OR INFLAMMATION (RFA-DK-02-002)
Letter of Intent Receipt Date: February 15, 2002; Application Receipt Date: March 15, 2002
This Request for Applications (RFA) is a reissue of RFA DK-99-018 "Imaging Pancreatic Beta Cell Mass, Function, or Inflammation", and is intended to further stimulate the development of techniques or reagents leading to the ability to image or otherwise noninvasively detect pancreatic islet beta cells in vivo, and measure their mass, function, or evidence of inflammation, or to monitor engraftment of transplanted isolated pancreatic islets.
- COGNITIVE NEUROIMAGING: UNDERSTANDING THE LINK BETWEEN NEURONAL ACTIVITY AND FUNCTIONAL IMAGING SIGNALS (RFA-NS-02-009)
Functional brain imaging techniques that take advantage of the changes in hemodynamic responses of the brain (positron emission tomography, functional magnetic resonance imaging, and infrared imaging) have emerged as promising new avenues for studying the neural basis of many different cognitive activities.
- NCI TRANSITION CAREER DEVELOPMENT AWARD (K22)(PAR-01-134)
This K22 award is intended to facilitate the transition of investigators from the mentored to the independent stage of their careers in CANCER research, by providing "protected time" for newly independent investigators to develop and receive support for their initial CANCER research programs. The award applies to clinicians who are pursuing basic science careers; clinicians who are pursuing careers in patient-oriented research; and to individuals pursuing careers in the prevention, control and population sciences. To apply, a candidate must have completed TWO YEARS OR MORE of postdoctoral, mentored research or have been in an independent position for LESS THAN TWO YEARS at the time the application is submitted.
- PATHOGENESIS AND TREATMENT OF INFLAMMATORY MUSCLE DISEASE (PA-01-131)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Dental and Craniofacial Research (NIDCR) encourage investigator-initiated research grant applications on pathogenesis and treatment of inflammatory myopathy. Responses to this program announcement may include studies in appropriate animal models or preclinical or clinical studies in patients with any form of inflammatory muscle disease.
- INNOVATIVE AND EXPLORATORY RESEARCH IN DIGESTIVE DISEASES AND NUTRITION (PA-01-129)
The Division of Digestive Diseases and Nutrition at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications through the exploratory/developmental (R21) grant mechanism from investigators with research interests in gastroenterology, hepatology, obesity and nutrition and that serve the mission of NIDDK. The R21 funding mechanism is being employed.
- SURROGATE ENDPOINTS FOR DIABETIC MICROVASCULAR COMPLICATIONS (RFA-DK 02-016)
Letter of Intent Receipt Date: January 17, 2002; Application Receipt Date: February 14, 2002
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Eye Institute (NEI) and the National Institute of Neurological Disorders and Stroke (NINDS) seek applications to develop and validate biomarkers for the microvascular complications of diabetes.
- EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM (NCRR) (PAR-01-130)
Application Receipt Dates: October 1 and February 1, annually
The National Center for Research Resources (NCRR) is authorized to "make grants or contracts to public and nonprofit private entities to expand, remodel, renovate, or alter existing research facilities or construct new research facilities." The facilities will be used for basic and clinical biomedical and behavioral research and research training.
- PILOT AND FEASIBILITY PROGRAM RELATED TO THE KIDNEY (PA-01-127)
The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Biology of Aging Program of the National Institute on Aging (NIA) and the Cancer Cell Biology Branch of the National Cancer Institute (NCI) invites applications through the exploratory/developmental (R21) grant mechanism from investigators with research interests related to the kidney and fall within the purview the NIH mission.
- FEASIBILITY PROGRAM IN HEMATOLOGICAL DISEASES (PA-01-128)
The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications through the exploratory/developmental (R21) grant mechanism from investigators with research interests in hematology and that serve the mission of NIDDK.
Other Government Agenices
- Biomedical Engineering Program and Research to Aid Persons with Disabilities Program (NSF) (BME/RAPD) (NSF-01-12)
DEADLINE(S): October 12, 2001; Unsolicited proposals will be accepted annually between September 1st and the second Friday in October.
The BME/RAPD programs encompass (a) the Biomedical Engineering program (BME) and (b) the Research to Aid Persons with Disabilities program (RAPD). Biomedical Engineering supports research that, often with diagnosis or treatment-related goals, applies engineering principles to problems in biology and medicine while advancing the engineering knowledge base. Integration of engineering expertise with life science principles is an essential requirement for advances in this field. Current areas of particular interest in BME/RAPD are biomedical photonics; novel tissue characterization schemes; new cellular and tissue engineering concepts; the innovative integration of multi-disciplinary technologies for new imaging and biosensing systems.
- ACRIN FELLOWSHIP (American College of Radiology and RSNA Research and Education Fund) Applications must be received by December 15, 2001.
The Fellows will receive training and experience in the development and conduct of rigorous, multidisciplinary, multi-institutional clinical trials of medical imaging technologies, working with ACRIN, a National Cancer Institute Clinical Trials Cooperative Group. The Fellowship will consist of both didactic and experiential components. The didactic component (July-September, 2002) consists, sequentially, of one month each at ACRIN Headquarters in Philadelphia, the ACRIN Biostatistical and Data Management Center at Brown University, and the NIH Cancer Imaging Program. For the succeeding nine months, Fellows will increasingly assume leadership roles in ACRIN trials, working out of their home institutions. Contact the ACRIN Administrator, Irene Mahon, 215-574-3231.
- AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) AWARDS AND FELLOWSHIPS
AACR offers research support for a growing number of promising early career scientists engaged in cancer research anywhere in the world. The application deadline is November 1, 2001. There are no citizenship or residency requirements for these awards and fellowships. Select the award or fellowship from the list below for further details and application materials.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507